Molotinib

About this medicine

Originator: OJJAARA by GLAXOSMITHKLINE · Manufacturer: TLPH Pharma. Indication & Dosage: Molotinib (Momelotinib), generic OJJAARA is a prescription medicine used to treat treatment of intermediate to high-risk myelofibrosis (MF) in adults with anemia. This includes primary myelofibrosis (PMF) as well as secondary myelofibrosis arising from post-polycythemia vera (PV) or post-essential thrombocythemia (ET). Molotinib manufactured by TLPH Pharma Ltd. in Laos. Momelotinib has to take orally once a daily with or without food as directed by patients doctor. Side Effects: The most common side effects of Momelotinib are: Thrombocytopenia (low platelet counts), Hemorrhage (bleeding), Bacterial infections, Fatigue, Dizziness, Diarrhea, Nausea. The above information comes from the Internet. Please consult with doctor for medical advice.

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.